Investing in cannabis stocks is back in focus as regulatory progress and expanding medical use steadily lift demand. The sector still mixes high upside with policy and execution risk, so being picky matters.
Barchart's screener shows these three cannabis names stand out for 2026. WM Technology (MAPS) offers exposure to clinical-stage pipelines and potential regulatory catalysts, Green Thumb Industries (GTBIF) provides retail and wholesale growth with improving margins as operations scale, and Corbus Pharmaceuticals (CRBP) delivers agricultural scale and branded-product leverage as adult-use markets stabilize. Together, these selections balance near-term operational gains with long-term commercial upside, offering a practical approach to cannabis exposure for the new year.
